PDCD1 and malignant colon neoplasm: Moreover, in the context of immune-hot CT26 colon cancer, RocA demonstrated a definite anti-tumor effect and promoted tumor suppressive activity of anti-PD-1 antibody, but RocA did not increase the quantity of T cells in the spleen and tumor microenvironment of mice.